Prime Medicine Inc (PRME)

Date: O: H: L: C: Vol:

Finanzdaten der Prime Medicine Inc-Aktie (PRME)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	13.73%44.44	51.51	49.45	55.20	54.49
Research and Development	2.08%33.40	34.11	34.71	43.99	41.38
Operating Income/Loss	14.55%-43.29	-50.65	-48.61	-53.97	-53.38
Nonoperating Income/Loss	23.24%1.18	1.53	2.53	3.39	0.79
	14.28%-42.11	-49.12	-46.08	-50.58	-52.59
Attributable To Parent	14.28%-42.11	-49.12	-46.08	-50.58	-52.59
Available To Common Stockholders, Basic	14.28%-42.11	-49.12	-46.08	-50.58	-52.59
Basic Average Shares	0.07%177.22	177.10	9.51	160.50	129.19
Diluted Average Shares	0.07%177.22	177.10	9.51	160.50	129.19
Basic Earnings Per Share	14.29%-0.24	-0.28	-0.24	-0.32	-0.41
Diluted Earnings Per Share	14.29%-0.24	-0.28	-0.24	-0.32	-0.41